Your session is about to expire
← Back to Search
Behavioural Intervention
IMPROVED intervention for Cancer
N/A
Waitlist Available
Led By Ryan Nipp
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial is testing a new method of cancer care delivery for patients.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of days with improved symptoms between study arms
Secondary outcome measures
Change in patients' symptom scores from baseline to discharge
Hospital length of stay (measured continuously as days admitted to the hospital) between study arms
Hospital readmissions within 30 days of prior hospital discharge between study arms
+2 moreOther outcome measures
Age as a moderator of the effect of IMPROVED on hospital length of stay
Age as a moderator of the effect of IMPROVED on hospital readmissions
Age as a moderator of the effect of IMPROVED on symptom burden
+13 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: IMPROVED interventionExperimental Treatment1 Intervention
Patients randomized to the IMPROVED intervention will self-report their symptoms each day using a tablet computer. If any patient refuses or is unable to complete the symptom assessment on the computer, the study team will permit them to use paper versions. At morning rounds each day, the clinical team will view reports detailing their patients' symptom burden. Patients randomized to IMPROVED will have their symptoms presented to their inpatient oncology team, but the study team will not provide guidance about what actions to take in response to patients' symptoms.
Group II: Usual CareActive Control1 Intervention
Usual Care per hospital standard will be administered. Participants receiving usual care will also self-report their symptoms each day using tablet computers. However, these patients' clinicians will not receive their symptom reports.
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,934 Previous Clinical Trials
13,198,191 Total Patients Enrolled
Alliance for Clinical Trials in Oncology Cancer Control Program (CCP)UNKNOWN
Ryan NippPrincipal InvestigatorMassachusetts General Hospital
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still vacancies available for participants in this experiment?
"The clinicaltrials.gov website reports that the trial, which was initially registered on February 12th 2018 and last updated April 4th 2022 is not currently recruiting participants. Fortunately, there are still 487 other trials actively enrolling individuals at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger